Cancer News and Research

Latest Cancer News and Research

Pancreatic cancer vaccine extends survival

In a long awaited positive development, an experimental pancreatic cancer vaccine seems to be extending survival rates higher.

16 Nov 2005

Tamoxifen reduces long-term risk of cancer

According to a new study released this week, women at high risk for breast cancer who take the well-known drug Tamoxifen, can reduce their long-term risk of developing the disease.

16 Nov 2005

Cannabis-based medicine given go-ahead to treat MS patients

Sufferers in the UK from multiple sclerosis and possibly rheumatoid arthritis, will welcome the news that they will soon be able to obtain an unlicensed, cannabis-based medicine on prescription to treat their illness.

16 Nov 2005

Gene therapy potential of the protein vasostatin for treatment of pancreatic cancer

A gene responsible for the production of a protein called vasostatin may prove a promising new way of treating pancreatic cancer, suggests research published ahead of print in Gut.

15 Nov 2005

Better understanding of cancer cachexia

New research shows that a wasting condition responsible for nearly a third of all cancer deaths involves the loss of an essential muscle protein that is also lost in people with muscular dystrophy.

15 Nov 2005

FLT-1 blockers, cutting the legs of leukaemia

Leukaemia is characterised by an uncontrolled growth of abnormal blood cells in the bone marrow (BM).

14 Nov 2005

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

Warnings to be put on condoms

The U.S. Food and Drug Administration (FDA) is calling for warnings to be placed on condoms.

14 Nov 2005

Race may play a role in whether a patient accepts surgical treatment for lung cancer

A study in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), found that blacks with lung cancer declined surgery at a higher rate than whites

14 Nov 2005

Speed of PSA increase matters more than PSA level

In the largest study of its kind to date, Mayo Clinic researchers report that prostate specific antigen (PSA) kinetics, both velocity and doubling time, can be used to predict disease progression and likelihood of death after radical prostatectomy surgery, suggesting that this could be used to guide treatment decisions.

14 Nov 2005

Bright light therapy may aid patients with depressive and bipolar disorders

A report in the November Cell Metabolism reveals powerful effects of light on the adrenal glands, a finding that might explain the broad benefits of bright light therapy for a variety of conditions, including sleep and depressive disorders, according to researchers.

14 Nov 2005

Fentanyl transdermal patch is an effective way to control pain in children

A new study says using a transdermal patch to deliver the opioid fentanyl is an effective way to control pain in children

14 Nov 2005

Biomedical device allows stem cells derived from adult bone marrow to be grown in sufficient quantities to permit far more research

Human stem cells offer tremendous hope for the development of revolutionary medical treatments for these and a variety of other human health problems.

14 Nov 2005

Prevalence of major psychiatric disorders is as common in cancer patients

The prevalence of major psychiatric disorders is as common in cancer patients as they are in the general population, with the exception of panic disorder which had elevated rates compared to the general population (5 percent versus 1.7 percent, respectively).

14 Nov 2005

Fundamental flaws in many medical studies must be fixed in order to catch signs of harm

Only by analyzing results using a statistical method that considers several factors at once -- for instance, overall heart attack risk, rather than just individual risk factors such as age -- will researchers truly be able to see how the risks and benefits of a treatment vary from patient to patient, the study suggests.

14 Nov 2005

Discovery of novel form of regulation of the GLI1 gene

The Quaking gene, first described as a mutation in mice that causes rapid tremor, is thought to suppress tumor formation and protect humans from cancer.

14 Nov 2005

First step in exploring the GnRH reproduction-related circuitry in the brain

Howard Hughes Medical Institute researchers have discovered a vast network of neurons in the brain of mice that governs reproduction and controls the effects of reproductive status on other brain functions.

14 Nov 2005

Researchers can now identify patients likely to respond to cancer drug therapy

Researchers at UCLA's Jonsson Cancer have identified key characteristics in certain deadly brain tumors that make them 51 times more likely to respond to a specific class of drugs than tumors in which the molecular signature is absent.

13 Nov 2005

Zyflamend shows promise in the early treatment of prostate cancer

Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."

13 Nov 2005

Cancer survivors require tailored follow-up plans

Citing shortfalls in the care currently provided to the country's 10 million cancer survivors, a new report recommends that each cancer patient receive a "survivorship care plan."

13 Nov 2005